Patents by Inventor Alan John Nimmo

Alan John Nimmo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Brain, spinal, and nerve injury treatment
    Patent number: 10201568
    Abstract: A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: February 12, 2019
    Assignee: EUSTRALIS PHARMACEUTICALS LIMITED
    Inventors: Alan John Nimmo, Robert Vink
  • BRAIN, SPINAL, AND NERVE INJURY TREATMENT
    Publication number: 20180071333
    Abstract: A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound.
    Type: Application
    Filed: September 25, 2017
    Publication date: March 15, 2018
    Inventors: Alan John Nimmo, Robert Vink
  • Brain, Spinal and Nerve Injury Treatment
    Publication number: 20160030474
    Abstract: A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound.
    Type: Application
    Filed: October 13, 2015
    Publication date: February 4, 2016
    Inventors: Alan John Nimmo, Robert Vink
  • Brain, spinal and nerve injury treatment
    Patent number: 9186404
    Abstract: A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound.
    Type: Grant
    Filed: June 1, 2009
    Date of Patent: November 17, 2015
    Assignee: EUSTRALIS PHARMACEUTICALS LIMITED
    Inventors: Alan John Nimmo, Robert Vink
  • METHOD FOR REDUCING INFLAMMATORY RESPONSES AND INFLAMMATION
    Publication number: 20100311803
    Abstract: The present invention relates a method of preventing and/or reducing an inflammatory response and/or inflammation in one or more tissues. The method includes delivering to the one or more tissues an effective amount of a substance P receptor antagonist.
    Type: Application
    Filed: December 7, 2007
    Publication date: December 9, 2010
    Inventors: Alan John Nimmo, Karen Margaret Whitfield, Konrad Reardon, Robert Vink
  • METHOD AND COMPOSITION FOR REDUCING REPERFUSION INJURY
    Publication number: 20100305183
    Abstract: The present invention relates to a method of preventing and/or reducing reperfusion injury to a tissue, organ, or organ system in a subject. The method includes administering to the subject an effective amount of a substance P receptor antagonist.
    Type: Application
    Filed: December 7, 2007
    Publication date: December 2, 2010
    Inventors: Alan John Nimmo, Karen Margaret Whitfield, Renée Jade Turner, Robert Vink
  • Brain, Spinal and Nerve Injury Treatment
    Publication number: 20090253698
    Abstract: A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound.
    Type: Application
    Filed: June 1, 2009
    Publication date: October 8, 2009
    Inventors: Alan John Nimmo, Robert Vink
  • Brain, spinal, and nerve injury treatment
    Patent number: 6841551
    Abstract: A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound.
    Type: Grant
    Filed: January 18, 2001
    Date of Patent: January 11, 2005
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Alan John Nimmo, Robert Vink
  • Brain, spinal, and nerve injury treament
    Publication number: 20030109417
    Abstract: A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound.
    Type: Application
    Filed: October 15, 2002
    Publication date: June 12, 2003
    Inventors: Alan John Nimmo, Robert Vink